Treatment with cytarabine at initiation of therapy with cyclosporine and glucocorticoids for dogs with meningoencephalomyelitis of unknown origin is not associated with improved outcomes

HIGHLIGHTS

  • who: Renee Barber from the Department of Small Animal Medicine and Surgery, College of Medicine, University of Georgia, Athens, GA, United States have published the research: Treatment With Cytarabine at Initiation of Therapy With Cyclosporine and Glucocorticoids for Dogs With Meningoencephalomyelitis of Unknown Origin Is Not Associated With Improved Outcomes, in the Journal: (JOURNAL)
  • what: The aim was to determine if short-term (i.e., 1 and 3month) relapse and mortality rates were improved with addition of a single administration of cytarabine either intravenously or subcutaneously at the time of diagnosis. It is unclear if . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?